Botha J F, Botha J R
Department of Surgery, Johannesburg Hospital.
S Afr J Surg. 1997 Aug;35(3):113-6.
The aim of this retrospective study was to assess parathyroid function after renal transplantation in patients with good renal function (creatinine < 133 mumol/l).
Of 1,628 patients on whom we performed renal transplantation, 210 have stable good renal function as defined above. Total calcium (Ca), creatinine, albumin and parathyroid hormone (PTH) values were obtained from patient records at varying intervals after transplantation, and in 91/210 patients pre-transplant values were available. Patients who had undergone parathyroidectomy before the transplant were excluded from the study. Follow-up ranged from 6 months to 24 years.
These 210 patients were divided into 4 groups according to PTH and Ca levels. Group 1 consisted of 118 patients (56%) with normal Ca and PTH levels and group 2 of 69 patients (33%) with normal Ca but persistently high PTH levels, of whom 25 persistently have Ca levels in the high normal range. The reason for the inappropriate PTH levels is not obvious. In group 3 there were 18 patients (8%) with high Ca and PTH levels. They have disease requiring parathyroidectomy. Group 4 comprised 5 patients (3%) with low Ca and high PTH levels. In the 91 patients for whom pre-transplant PTH values were available, 16/46 patients with tertiary hyperparathyroidism (3 degrees HPT) have normalised after transplant, 12/46 patients have ongoing 3 degrees HPT post transplant, while 4/45 patients with less severe disease (secondary HPT) have developed 3 degrees HPT (P < 0.059).
In 56% of patients with good renal function after transplant parathyroid function is normal. Thirty-three per cent have high PTH levels with normal Ca, but 36% of these are in the high normal range. Eight per cent have persistent 3 degrees HPT. Post-transplant parathyroid dysfunction correlates with the severity of pre-transplant disease.
本回顾性研究旨在评估肾功能良好(肌酐<133μmol/l)的肾移植患者的甲状旁腺功能。
在我们进行肾移植的1628例患者中,210例具有上述定义的稳定良好肾功能。在移植后的不同时间间隔从患者记录中获取总钙(Ca)、肌酐、白蛋白和甲状旁腺激素(PTH)值,并且在91/210例患者中可获得移植前的值。移植前接受过甲状旁腺切除术的患者被排除在研究之外。随访时间为6个月至24年。
这210例患者根据PTH和Ca水平分为4组。第1组由118例(56%)Ca和PTH水平正常的患者组成,第2组由69例(33%)Ca正常但PTH水平持续升高的患者组成,其中25例Ca水平持续处于高正常范围。PTH水平异常的原因不明显。第3组有18例(8%)Ca和PTH水平升高的患者。他们患有需要甲状旁腺切除术的疾病。第4组包括5例(3%)Ca低而PTH水平高的患者。在可获得移植前PTH值的91例患者中,16/46例三发性甲状旁腺功能亢进(3度HPT)患者在移植后恢复正常,12/46例患者移植后仍有持续性3度HPT,而4/45例病情较轻(继发性HPT)的患者发展为3度HPT(P<0.059)。
移植后肾功能良好的患者中,56%的患者甲状旁腺功能正常。33%的患者Ca正常但PTH水平升高,但其中36%处于高正常范围。8%的患者有持续性3度HPT。移植后甲状旁腺功能障碍与移植前疾病的严重程度相关。